Special Report Jonathan Moens Costly Alzheimer’s treatment is spreading around the world, with virtually no science to back it up
Special Report Megan Molteni From burst bubble to medical marvel: How lipid nanoparticles became the future of gene therapy
Special Report Matthew Herper How Paxlovid came to be: From the germ of an idea to a vital tool against Covid
Special Report STAT Staff Covid hasn’t given up all its secrets. Here are 6 mysteries experts hope to unravel
Special Report Usha Lee McFarling 20 years ago, a landmark report spotlighted systemic racism in medicine. Why has so little changed?
Special Report Adam Feuerstein and Damian Garde Biogen’s reckoning: How the Aduhelm debacle pushed a troubled company and its fractured leadership to the brink
Prescription Politics Lev Facher More than two-thirds of Congress cashed a pharma campaign check in 2020, new STAT analysis shows
Special Report Angus Chen This clinical trial wanted to end breast cancer disparities. But first it needed to enroll Black women
Special Report Andrew Joseph To protect people with addiction from discrimination, the Justice Dept. turns to a long-overlooked tool: the ADA
Special Report Todd Feathers, Simon Fondrie-Teitler, Angie Waller, and Surya Mattu — The Markup Facebook is receiving sensitive medical information from hospital websites
Special Report Angus Chen ‘How do you decide?’: Cancer treatment’s CAR-T crisis has patients dying on a waitlist
Special Report Tara Bannow Hospitals have been financially propping up medical schools, but now it’s squeezing their bottom lines
Special Report Lev Facher NIH’s identity crisis: The pandemic and the search for a new leader leave the agency at a crossroads
Special Report Rachel Cohrs Why formally ending the pandemic is going to be a huge headache for the entire health care system
Special Report Usha Lee McFarling The nation hasn’t made much progress on health equity. These leaders forged ahead anyway
Special Report Casey Ross How a decades-old database became a hugely profitable dossier on the health of 270 million Americans
Special Report Isabella Cueto Jolting the brain’s circuits with electricity is moving from radical to almost mainstream therapy. Some crucial hurdles remain
Special Report Damian Garde It’s the cardiovascular version of Alzheimer’s — and, for a biotech with a promising drug, it could be a windfall
Special Report Olivia Goldhill — STAT and Rosa Furneaux and Madlen Davies — TBIJ ‘Naively ambitious’: How COVAX failed on its promise to vaccinate the world
Exclusive Nicholas Florko ‘Change is messy’: Inside the tumultuous efforts to stabilize BIO, the biotech lobby
Special Report Lev Facher ‘It’s soul-draining’: Health workers deployed to Covid hot zones are overwhelmed by deaths among the unvaccinated
Exclusive Adam Feuerstein, Matthew Herper and Damian Garde Inside ‘Project Onyx’: How Biogen used an FDA back channel to win approval of its polarizing Alzheimer’s drug
Special Report Nicholas St. Fleur and Hyacinth Empinado Watch: An unusual 30th birthday gift: Why I got a colonoscopy so young — and documented every step
Special Report Nicholas St. Fleur Chadwick Boseman’s tragedy is America’s tragedy: In colorectal cancer hot spots, young men are dying at higher rates
Prescription Politics Lev Facher Pharma funded more than 2,400 state lawmaker campaigns in 2020, new STAT analysis finds
Special Report Helen Branswell As Covid dissipates in the U.S., cold and flu viruses may return with a vengeance
Special Report Olivia Goldhill Shuttered hospitals, soaring Covid-19 deaths: Rural Black communities lose a lifeline in the century’s worst health crisis